Clinical Trial Update: Extended LH Administration [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating extended luteinizing hormone (LH) administration for ovarian reserve is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Reserve

Drugs mentioned

• Luteinizing hormone (LH) (Luteinizing hormone)

Snippet

Sponsor: Azienda Ospedaliero-Universitaria di Modena | Conditions: Ovarian Reserve | Phase 2 | Status: NOT_YET_RECRUITING